The robotics giant revealed on an earnings call that it won FDA clearance for several cardiac procedures and is also ramping ...

Intuitive Surgical receives FDA clearance for the da Vinci 5 robot to be used in cardiac procedures, reports 18% procedure ...

Intuitive CEO Dave Rosa highlighted that the clearance related to “several cardiac” procedures for non-force instruments used ...

Over 3 million procedures were performed globally on Intuitive daVinci systems last year, accounting for an 18% increase.

The FDA 510(k) clearances for cardiac procedures cover Intuitive's latest-generation da Vinci 5 (DV5) using non-Force ...

CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving ...

SUNNYVALE, Calif., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced that more ...

I reiterate a 'Sell' rating on Intuitive Surgical with a fair value of $350 per share due to its hefty valuation. The Da Vinci 5 robot rollout in mid-2025 is a major catalyst, with significant growth ...

The bullish case for the stock remains strong.

Intuitive Surgical, Inc. has reported past fourth-quarter 2025 revenue of US$2.87 billion and full-year revenue of US$10.06 billion, alongside higher net income and earnings per share compared with ...

SUNNYVALE, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that ...

Robotic-assisted surgery stalwart Intuitive Surgical (NASDAQ: ISRG) blew investors away with its Q3 2025 earnings report back ...